Metabolic & Cardiometabolic Outcomes
Medication use, health measurements and lifestyle observations for metabolic and cardiovascular outcome questions.
Define the corpus
Scope a longitudinal cohort around metabolic treatment patterns, measurements and daily behavior. Define the required diagnosis criteria, measures, units and follow-up period before assessing clinical-record or device linkage.
Fields to assess
- Medication records and reported adherence
- Weight, blood pressure and glucose observations where recorded
- Activity, sleep and nutrition observations
- Eligible laboratory results and wearable measurements
Field-level coverage, missingness and provenance are confirmed during feasibility review. Listed modalities are not a promise of availability.
Project applications
- Treatment persistence and adherence
- Measurement trajectories
- Lifestyle and symptom relationships
- Health economics and outcomes research
Data interpretation
Patient-entered, device-derived and laboratory measurements are distinguished in the data specification. Measurement units, frequency and clinical verification require review.
Cohort and delivery specification
Request the condition definition, unique participant count, geography, observation period, follow-up distribution, field coverage and update schedule. The specification distinguishes self-reported observations, device measurements and clinical-record-derived fields.
Clinical coding, measurement units, data dictionaries, missingness and de-identification are reviewed for the proposed delivery. Clinical images and reports are assessed separately from original DICOM studies; genetic test summaries are assessed separately from raw variants, sequencing and omics matrices.
Licensing and due diligence
Annual licenses, defined-project access and refreshes can be discussed after feasibility review. Research, AI evaluation, model training, derivative models, sublicensing and exclusivity require specific written permissions. Patient recontact is not included in an inquiry or implied by a data license.
Source provenance, the legal supplier or controller and its authority to license are disclosed during buyer due diligence. These profiles may draw on overlapping populations; counts are not added across products.
Tell us the cohort you need.
Include conditions, required fields, follow-up and intended use. No patient records are needed to make an inquiry.